2019 SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

November 20 - 21, 2019
Marriott Desert Ridge Hotel, Phoenix, Arizona

Held in conjunction with the 24th Annual Meeting and Education Day of
the Society for Neuro-Oncology

NOW ACCEPTING ABSTRACTS - DEADLINE JUNE 24, 2019, 11:59pm
Click here to submit your abstract



Conference Overview
The Society for Neuro-Oncology (SNO) and the Society for CNS Interstitial Delivery of Therapeutics (SCIDOT) invite you to attend the 2019 SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS which will be held on November 20-21, 2019 at the Marriott Desert Ridge Hotel in Phoenix, Arizona (in conjunction with the SNO Annual Meeting).  This important meeting will focus on the critical theme of drug delivery to the CNS, highlighting barriers, as well as potential new avenues and ground-breaking research. The program committee is developing a robust program that will include invited talks from industry professionals and leaders in the field, as well as select oral and poster abstract presentations.

Abstract Categories/Session Topics
BBB Physiology  
Phase 0/Tissue Analysis Based Trials        
Pre-clinical Therapeutic Development     
Clinical Trials in Neuro-Oncology 
Clinical Trials in Other Areas        
New Technologies for Drug/Biologic Delivery       
Modeling and Imaging    
Technologies for CNS Directed Therapy  


We invite industry, pharmaceutical, and foundation support. To download the prospectus, click here. 

Click the links below to register and reserve your hotel room

Registration. Note that registration cannot be combined with the main SNO meeting registration. To register separately for the SNO meeting, click here. 
Early bird pricing:
Full registration: $395
Trainee registration: $235
Register by September 11 for early bird rates

Hotel accommodations
Conference Hotel: JW Marriott Desert Ridge Hotel
Phoenix, Arizona


 


Program Committee:
SCIDOT Chair - Michael Vogelbaum, MD, PhD, Moffitt Cancer Center
SNO Chair - Nathalie Agar, PhD, Dana-Farber Cancer Institute

Krystof Bankiewicz, MD, PhD, University of California, San Francisco
Waldemar Debinski, MD, PhD, Wake Forest University
William Elmquist, PhD, University of Minnesota
Raghu Raghavan, PhD, Therataxis, LLC
Nader Sanai, MD, Barrow Neurological Institute
Lisa Shafer, PhD, Neuro Connect Consulting
Mark Souweidane, MD, Weill Cornell Brain and Spine Center
Manfred Westphal, MD, University Hospital Hamburg-Eppendorf